Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Looney, James E.a; | Knight, David M.a | Arevalo-Moore, Mariaa | Trinh, Hana | Pak, Koon-Yanb | Dalesandro, Margaret R.b | Rieber, E. Peterc | Riethmuller, Gertc | Daddona, Peter E.b | Ghrayeb, Johna
Affiliations: [a] Department of Molecular Biology, Centocor, Malvern, PA, USA | [b] Department of Immunobiology, Centocor, Malvern, PA, USA | [c] Institute for Immunology, University of Munich, Munich, Germany
Note: [] Address reprint requests to Dr. James Looney, Department of Molecular Biology, Centocor, Inc., 200 Great Valley Parkway, Malvern, PA 19355, USA.
Abstract: The use of murine anti-CD4 monoclonal antibodies (MAbs) has shown considerable promise for the treatment of allograft rejection and rheumatoid arthritis. We have constructed mouse-human anti-CD4 antibodies with the goal of increasing their clinical potential by decreasing immunogenicity and improving effector functions. The chimeric antibodies were constructed by cloning the heavy and light chain variable regions of M-T412, a murine antibody raised against the human CD4 antigen, and joining them to the human G1, G4, or kappa constant regions in mammalian expression vectors. After transfection into mouse myeloma cells, stable cell lines were isolated that secrete up to 140 μg/ml chimeric antibody in static culture. The chimeric antibodies were equivalent to the murine antibody in their binding characteristics and relative affinities. However, the chimeric M-T412 MAbs have enhanced activity when compared to the murine G2a MAb in mediating antibody-dependent cell-mediated cytotoxicity using human CD4+ target and effector cells.
Keywords: chimeric monoclonal antibody, M-T412, CD4
DOI: 10.3233/HAB-1992-3405
Journal: Human Antibodies, vol. 3, no. 4, pp. 191-200, 1992
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
sales@iospress.com
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
info@iospress.nl
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office info@iospress.nl
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
china@iospress.cn
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
如果您在出版方面需要帮助或有任何建, 件至: editorial@iospress.nl